Search research articles
Contact Us
Filters
Showing results (261-270 of 288) with videos related to
Page
of 29
Sort By:
Cardiology Journal
|
February 26, 2021
Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry
Eun-Seok Shin, Eun Jung Jun, Jung-Kyu Han, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
Sergio Leonardi, Mattia Branca, Anna Franzone, et al.
International Journal of Cardiology
|
March 9, 2019
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study
Ply Chichareon, Rodrigo Modolo, David van Klaveren, et al.
BMJ Open
|
March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)
Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Journal of the American College of Cardiology
|
November 2, 2019
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
Anna Franzone, Eugène McFadden, Sergio Leonardi, et al.
Circulation
|
August 10, 2022
Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial
Rodney H Stables, Liam J Mullen, Mostafa Elguindy, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial
Kuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY
Felice Gragnano, Dik Heg, Anna Franzone, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial
Masafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
Journal of the American College of Cardiology
|
May 21, 2022
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Mattia Lunardi, Yves Louvard, Thierry Lefèvre, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 288) with videos related to
Sort By:
Page
of 29
Cardiology Journal
|
February 26, 2021
Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry
Eun-Seok Shin, Eun Jung Jun, Jung-Kyu Han, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
Sergio Leonardi, Mattia Branca, Anna Franzone, et al.
International Journal of Cardiology
|
March 9, 2019
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study
Ply Chichareon, Rodrigo Modolo, David van Klaveren, et al.
BMJ Open
|
March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)
Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Journal of the American College of Cardiology
|
November 2, 2019
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
Anna Franzone, Eugène McFadden, Sergio Leonardi, et al.
Circulation
|
August 10, 2022
Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial
Rodney H Stables, Liam J Mullen, Mostafa Elguindy, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial
Kuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY
Felice Gragnano, Dik Heg, Anna Franzone, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial
Masafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
Journal of the American College of Cardiology
|
May 21, 2022
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Mattia Lunardi, Yves Louvard, Thierry Lefèvre, et al.
Page
of 29